Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcCormack, M.-
dc.contributor.authorGonda, T.-
dc.identifier.citationBlood, 2000; 95(1):120-127-
dc.description.abstractSeveral activating mutations have recently been described in the common beta subunit for the human interleukin(IL)-3, IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors (hbetac). Two of these, FIDelta and I374N, result, respectively, in a 37-amino acid duplication and an isoleucine-to-asparagine substitution in the extracellular domain. A third, V449E, leads to valine-to-glutamic acid substitution in the transmembrane domain. Previous studies have shown that when expressed in murine hemopoietic cells in vitro, the extracellular mutants can confer factor independence on only the granulocyte-macrophage lineage while the transmembrane mutant can do so to all cell types of the myeloid and erythroid compartments. To further study the signaling properties of the constitutively active hbetac mutants, we have used novel murine hemopoietic cell lines, which we describe in this report. These lines, FDB1 and FDB2, proliferate in murine IL-3 and undergo granulocyte-macrophage differentiation in response to murine GM-CSF. We find that while the transmembrane mutant, V449E, confers factor-independent proliferation on these cell lines, the extracellular hbetac mutants promote differentiation. Hence, in addition to their ability to confer factor independence on distinct cell types, transmembrane and extracellular activated hbetac mutants deliver distinct signals to the same cell type. Thus, the FDB cell lines, in combination with activated hbetac mutants, constitute a powerful new system to distinguish between signals that determine hemopoietic proliferation or differentiation. (Blood. 2000;95:120-127)-
dc.publisherAmer Soc Hematology-
dc.subjectHematopoietic Stem Cells-
dc.subjectCell Line-
dc.subjectCell Line, Transformed-
dc.subjectMacromolecular Substances-
dc.subjectGlutamic Acid-
dc.subjectGranulocyte-Macrophage Colony-Stimulating Factor-
dc.subjectReceptors, Granulocyte-Macrophage Colony-Stimulating Factor-
dc.subjectReceptors, Interleukin-3-
dc.subjectRecombinant Proteins-
dc.subjectAmino Acid Substitution-
dc.subjectCell Differentiation-
dc.subjectRepetitive Sequences, Nucleic Acid-
dc.titleNovel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor b subunit-
dc.typeJournal article-
dc.identifier.orcidGonda, T. [0000-0002-8792-3021]-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.